Robert J. Deluccia

Filings by Robert J. Deluccia span 3 companies, the busiest being Macrochem Corp, Acurx Pharmaceuticals, Inc. and PLx Pharma Inc. In total, 18 filings cover trades dated from 10 February 2006 to 6 January 2025.

Purchases make up the whole of the open-market record (13 purchases, €187k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise. 2025 to date brings 1 purchase and no sales.

The median purchase comes to €1,038. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 8 January 2025, reports an open-market purchase of €49k in Acurx Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.